Cargando…
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
Herpes simplex viruses (HSV) are significant global health problems associated with mucosal and neurologic disease. Prior experimental vaccines primarily elicited neutralizing antibodies targeting glycoprotein D (gD), but those that advanced to clinical efficacy trials have failed. Preclinical studi...
Autores principales: | Burn Aschner, Clare, Pierce, Carl, Knipe, David M., Herold, Betsy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350019/ https://www.ncbi.nlm.nih.gov/pubmed/32516944 http://dx.doi.org/10.3390/vaccines8020277 |
Ejemplares similares
-
Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity
por: Burn Aschner, Clare, et al.
Publicado: (2020) -
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023) -
Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine
por: Mahant, Aakash Mahant, et al.
Publicado: (2023) -
Maternal Immunization with a Single-Cycle Herpes Simplex Virus (HSV) Candidate Vaccine, ΔgD-2, Protects Neonatal Mice from Lethal Viral Challenge
por: Kao, Carol, et al.
Publicado: (2017) -
Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry
por: Cheshenko, Natalia, et al.
Publicado: (2018)